Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy

NEXT STORY
Chinook Therapeutics Announces First Patient Dosed in Phase 2 AFFINITY Basket Study of Atrasentan in Proteinuric Glomerular Diseases
PREV STORY
Global Atopic Eczema Treatment Market Will Reach USD 34,089.3 Million by 2026: Facts & Factors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

CytoDyn Reports Primary Endpoint Achieved in PRO 140 Pivotal Combination Therapy Trial in HIV Infection

VANCOUVER, Washington, Feb. 20, 2018 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB:CYDY) reports the successful ...

author_avatar
NASDAQ Market News

Fluidigm Introduces Imaging Mass Cytometry System for Highly Multiplexed Protein Detection in Tissues

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today ...

author_avatar
NASDAQ Market News

Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results

Total First-Quarter Revenues of $202.3 Million, Up 13 PercentFirst-Quarter Diluted EPS of ($0.01) and ...

author_avatar
NASDAQ Market News